Author: healthadmin

Alzheimer’s disease (AD) remains one of the most pressing global health challenges, especially as the aging population continues to grow. This condition steadily erodes memory and thinking skills, severely impacting daily life. New treatments, including monoclonal antibodies such as lecanemab and donanemab, have provided some optimism by slowing cognitive decline. However, these treatments still do not reverse the disease or restore normal brain function. Recently published reviews Science China Life Science Professor Yan-Jiang Wang and colleagues explore why progress has been limited. Researchers argue that focusing on a single cause is ineffective because Alzheimer’s disease is much more complex. This…

Read More

Novartis is cutting more jobs at its U.S. headquarters in New Jersey, with plans to eliminate 114 positions as it reorganizes its rare disease drug sales team. The Swiss pharmaceutical company telegraphed the job cuts in its recent Worker Adjustment and Retraining Notification (WARN) submission (PDF) to the canton, which is expected to take effect from late June to November. “Our U.S. customer engagement organization has been evaluating opportunities to evolve the structure of our field sales team to better support the unique needs of patients and customers in rare and ultra-rare disease areas, where Novartis has a strong presence…

Read More

Chesapeake Bay Landscape Specialist Jason Swope demonstrates road salting techniques in Gaithersburg, Maryland, on January 31, 2026. (S. Monsion/Potomac River Basin Interstate Commission) With the arrival of spring, salinity levels in many freshwater rivers in the Chesapeake Bay region will skyrocket. The salinity comes primarily from salt used to treat roads in the winter, which continues to flow toward rivers during the spring rains.And while efforts are underway across the region to reduce harmful salinity in freshwater streams, research shows that salinity continues to rise. John Jackson, principal investigator at Stroud Water Research Center in Pennsylvania, said rock salt is…

Read More

New research published in Sleep Health: National Sleep Foundation Journal suggests that depression and anxiety may play an increasingly large role in new parents’ sleep problems, especially as babies grow older. Becoming a parent is often said to be one of the most enjoyable experiences in life, but it can also be exhausting. Frequent night wakings, feeding schedules, and the stress of caring for a newborn can disrupt your sleep for months. Previous research has long linked sleep deprivation to mental health issues such as depression and anxiety, but most studies have focused only on mothers and the first few…

Read More

Thousands of illegal e-cigarettes are sold in the United States, and the Trump and Biden administrations have vowed to crack down on illegal fruit- and candy-flavored e-cigarettes that are especially appealing to minors. But a new government report suggests that the Justice Department’s enforcement efforts are far behind the scope of the problem. According to the Government Accountability Office report, most of the Justice Department’s enforcement actions from fiscal years 2022 to 2025 (50 of 88 total) involved adding the names of remote e-cigarette sellers to the list of unauthorized operators. The second most common type of enforcement action cited…

Read More

As geopolitics drive interest in reshoring to a fever pitch, the United States Pharmacopeia (USP) warns that it is focusing on drug building blocks known as critical starting materials, increasing the push for domestic drug production. In a new Supply Chain Vulnerabilities Update (PDF), USP, a nonprofit organization that helps set quality standards for pharmaceuticals, highlighted 100 acute and chronic medicines that are currently at risk of supply gaps and other disruptions, although not all are in short supply. According to USP, this is due to bottlenecks in the production chain, particularly at upstream stages focused on activities such as…

Read More

Sometimes not seeing something can be just as important as detecting it. This idea is at the heart of a new study published in the journal Journal of Cosmology and Astroparticle Physics (JCAP). The study suggests that scientists may not need to find the same signal everywhere in the universe to understand dark matter. This study focuses on puzzling observations. Astronomers have detected an excess of gamma rays at the center of the Milky Way. This can be created when dark matter particles collide and annihilate. However, similar signals have not been found elsewhere, such as in dwarf galaxies. According…

Read More

The editorial “Dynamics-driven medical big data mining: A dynamic approach to early disease prediction and personalized care” intelligent medicine (February 2026, Volume 6, Issue 1) was written by Lu Wang (Tianjin Medical University), Han Lyu (Beijing Friendship Hospital of Capital Medical University), and Bin Sheng (Shanghai Jiao Tong University). We argue that the future of medical AI lies not only in diagnosing diseases after they become visible, but also in detecting early dynamic changes that occur before symptoms are fully manifest. By analyzing how health data evolves over time, from omics and medical records to imaging and wearable devices, AI…

Read More

Envision Pharma Group has hired clinical research veteran Nick Jones as president of its Envision Medical Communications (EMC) business.Mr. Jones will lead the company’s EMC division, which works with biopharmaceutical and medical technology companies across areas such as medical affairs, commercialization and market access. According to an April 8 release, Jones’ primary focus will be on integrating Envision’s technology and AI capabilities into the company’s portfolio of solutions and services.He has a deep background in clinical research, including serving as SVP and GM of commercial solutions at ConcertAI, as well as more than 10 years at CRO and consulting firm…

Read More

A new study to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, May 11-14) showed that patients who used GLP-1 or GLP-1/GIP receptor agonist combination therapy for weight loss had minimal loss of lean muscle mass as they lost weight over a six-month treatment period. The study was conducted by Dr. Dinabel Peralta Reich of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Alexandra Filingheri and colleagues at Lenox Hill Hospital, Northwell Health, New York City, New York, USA, and New York Weight Wellness Medicine, New York City, USA. GLP-1 (glucagon-like peptide-1)…

Read More